{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:39:20Z","timestamp":1776706760321,"version":"3.51.2"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Non-small cell lung cancer is the most common malignancy of the lung, with over 40% of the cases in patients aged 75 years or older. Many of these patients are inoperable due to comorbidities, limiting treatment options. Stereotactic body radiotherapy (SBRT) offers a curative alternative, achieving local control (LC) rates similar to surgery with manageable toxicity. This retrospective analysis aimed to investigate the efficacy and safety of MRI-guided SBRT (MRIgSBRT) for elderly lung cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Data of patients aged\u2009\u2265\u200975 years, treated in our Institution between 2017 and 2023, were retrospectively collected. Survival curves for local recurrence-free survival (LRFS), progression-free survival and overall survival (OS) were estimated using the Kaplan\u2013Meier method. Toxicity was assessed using the Common Terminology Criteria for Adverse Events (CTCAE version 5.0) scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study included 38 patients with a total of 45 lung lesions, median age of 82 years (range 75\u201387). The median total radiotherapy dose was 62,5 Gy (range 24\u201375 Gy) delivered in 5 fractions (range 3\u20138). The median follow-up was of 16.9 months (range 0,97\u201366,7). The 1-, 2- and 3-year OS rates were 98% 96% and 80%, respectively, while the 1-, 2- and 3-year LRFS was 97,5%. Six patients (15.78%) and one patient (2.63%) had late G1 radiation-induced pneumonia and G2 dyspnoea, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MRIgSBRT is a valid therapeutic option for patients aged\u2009\u2265\u200975 with comorbidities, frailty and risk factors limiting their performance status and eligibility for invasive treatments, offering good LC and favourable toxicity profile.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11547-025-02056-1","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T10:19:59Z","timestamp":1753179599000},"page":"1625-1632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MRI-guided stereotactic body radiation therapy for very elderly patients with primary lung cancer: a retrospective analysis of safety and efficacy profiles"],"prefix":"10.1007","volume":"130","author":[{"given":"Luca","family":"Boldrini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9371-9951","authenticated-orcid":false,"given":"Angela","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Castan\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Lococo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Cicchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Nardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Panza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Placidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuditta","family":"Chiloiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"2056_CR1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP (2023) The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol 20:624\u2013639. https:\/\/doi.org\/10.1038\/s41571-023-00798-3","journal-title":"Nat Rev Clin Oncol"},{"key":"2056_CR2","unstructured":"American Lung Association (2024) Lung Cancer Mortality - Lung Cancer Trends Brief | American Lung Association. https:\/\/www.lung.org\/research\/trends-in-lung-disease\/lung-cancer-trends-brief\/lung-cancer-mortality-(1). Accessed 4 Oct 2024"},{"key":"2056_CR3","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/S1470-2045(23)00444-8","volume":"24","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Vaccarella S, Morgan E et al (2023) Global variations in lung cancer incidence by histological subtype in 2020: a population-based study. Lancet Oncol 24:1206\u20131218. https:\/\/doi.org\/10.1016\/S1470-2045(23)00444-8","journal-title":"Lancet Oncol"},{"key":"2056_CR4","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA: A Cancer Journal for Clinicians 73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763","DOI":"10.3322\/caac.21763"},{"key":"2056_CR5","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","volume":"7","author":"AK Ganti","year":"2021","unstructured":"Ganti AK, Klein AB, Cotarla I et al (2021) Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US. JAMA Oncol 7:1824\u20131832. https:\/\/doi.org\/10.1001\/jamaoncol.2021.4932","journal-title":"JAMA Oncol"},{"key":"2056_CR6","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1378\/chest.10-2841","volume":"140","author":"C Rivera","year":"2011","unstructured":"Rivera C, Falcoz P-E, Bernard A et al (2011) Surgical management and outcomes of elderly patients with early stage non-small cell lung cancer: a nested case-control study. Chest 140:874\u2013880. https:\/\/doi.org\/10.1378\/chest.10-2841","journal-title":"Chest"},{"key":"2056_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1053\/j.seminoncol.2018.06.002","volume":"45","author":"A Shinde","year":"2018","unstructured":"Shinde A, Li R, Kim J et al (2018) Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly. Semin Oncol 45:210\u2013219. https:\/\/doi.org\/10.1053\/j.seminoncol.2018.06.002","journal-title":"Semin Oncol"},{"key":"2056_CR8","doi-asserted-by":"publisher","unstructured":"Swaminath A, Parpia S, Wierzbicki M, Kundapur V, Faria S, Okawara GS, Tsakiridis TK, Ahmed N, Bujold A, Hirmiz K, Owen T, Leong N, Ramchandar K, Filion E, Lau H, Gabos Z, Thompson R, Yaremko B, Mehiri S, Whelan TJ (2024) Stereotactic vs hypofractionated radiotherapy for inoperable stage I non\u2013small cell lung cancer. JAMA Oncol 10(11):1571. https:\/\/doi.org\/10.1001\/jamaoncol.2024.3089","DOI":"10.1001\/jamaoncol.2024.3089"},{"key":"2056_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jgo.2017.07.002","volume":"8","author":"P Kreinbrink","year":"2017","unstructured":"Kreinbrink P, Blumenfeld P, Tolekidis G et al (2017) Lung stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer in the very elderly (\u2265 80 years old): Extremely safe and effective. J Geriatric Oncol 8:351\u2013355. https:\/\/doi.org\/10.1016\/j.jgo.2017.07.002","journal-title":"J Geriatric Oncol"},{"key":"2056_CR10","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00432-020-03154-5","volume":"146","author":"Z Shu","year":"2020","unstructured":"Shu Z, Dong B, Shi L et al (2020) Stereotactic body radiotherapy for elderly patients (\u2265 75 years) with early-stage non-small cell lung cancer. J Cancer Res Clin Oncol 146:1263\u20131271. https:\/\/doi.org\/10.1007\/s00432-020-03154-5","journal-title":"J Cancer Res Clin Oncol"},{"key":"2056_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13014-021-01769-7","volume":"16","author":"K Watanabe","year":"2021","unstructured":"Watanabe K, Katsui K, Sugiyama S et al (2021) Lung stereotactic body radiation therapy for elderly patients aged \u2265 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study. Radiat Oncol 16:39. https:\/\/doi.org\/10.1186\/s13014-021-01769-7","journal-title":"Radiat Oncol"},{"key":"2056_CR12","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1200\/JCO.18.00622","volume":"37","author":"A Bezjak","year":"2019","unstructured":"Bezjak A, Paulus R, Gaspar LE et al (2019) Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non\u2013small-cell lung cancer: NRG oncology\/RTOG 0813 trial. JCO 37:1316\u20131325. https:\/\/doi.org\/10.1200\/JCO.18.00622","journal-title":"JCO"},{"key":"2056_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13014-019-1308-y","volume":"14","author":"S Corradini","year":"2019","unstructured":"Corradini S, Alongi F, Andratschke N et al (2019) MR-guidance in clinical reality: current treatment challenges and future perspectives. Radiat Oncol 14:92. https:\/\/doi.org\/10.1186\/s13014-019-1308-y","journal-title":"Radiat Oncol"},{"key":"2056_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/acm2.12697","volume":"20","author":"D Cusumano","year":"2019","unstructured":"Cusumano D, Boldrini L, Menna S et al (2019) Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer. J Appl Clin Med Phys 20:20\u201330. https:\/\/doi.org\/10.1002\/acm2.12697","journal-title":"J Appl Clin Med Phys"},{"key":"2056_CR15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13014-020-01530-6","volume":"15","author":"D Cusumano","year":"2020","unstructured":"Cusumano D, Dhont J, Boldrini L et al (2020) Reliability of ITV approach to varying treatment fraction time: a retrospective analysis based on 2D cine MR images. Radiat Oncol 15:152. https:\/\/doi.org\/10.1186\/s13014-020-01530-6","journal-title":"Radiat Oncol"},{"key":"2056_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/acm2.13030","volume":"21","author":"L Placidi","year":"2020","unstructured":"Placidi L, Cusumano D, Boldrini L et al (2020) Quantitative analysis of MRI-guided radiotherapy treatment process time for tumor real-time gating efficiency. J Appl Clin Med Phys 21:70\u201379. https:\/\/doi.org\/10.1002\/acm2.13030","journal-title":"J Appl Clin Med Phys"},{"key":"2056_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2023.100488","volume":"4","author":"ML Sandoval","year":"2023","unstructured":"Sandoval ML, Sim AJ, Bryant JM et al (2023) Magnetic resonance-guided stereotactic body radiation therapy\/hypofractionated radiation therapy for metastatic and primary central and ultracentral lung lesions. JTO Clin Res Rep 4:100488. https:\/\/doi.org\/10.1016\/j.jtocrr.2023.100488","journal-title":"JTO Clin Res Rep"},{"key":"2056_CR18","doi-asserted-by":"publisher","unstructured":"Lababede O, Meziane MA (2018) The eighth edition of tnm staging of lung cancer: reference chart and diagrams. Oncologist 23:844\u2013848. https:\/\/doi.org\/10.1634\/theoncologist.2017-0659","DOI":"10.1634\/theoncologist.2017-0659"},{"key":"2056_CR19","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","volume":"21","author":"M Guckenberger","year":"2020","unstructured":"Guckenberger M, Lievens Y, Bouma AB et al (2020) Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol 21:e18\u2013e28. https:\/\/doi.org\/10.1016\/S1470-2045(19)30718-1","journal-title":"Lancet Oncol"},{"key":"2056_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"2056_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.semradonc.2014.02.008","volume":"24","author":"S Mutic","year":"2014","unstructured":"Mutic S, Dempsey JF (2014) The viewray system: magnetic resonance-guided and controlled radiotherapy. Seminars Radiat Oncol 24:196\u2013199. https:\/\/doi.org\/10.1016\/j.semradonc.2014.02.008","journal-title":"Seminars Radiat Oncol"},{"key":"2056_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ctro.2019.04.007","volume":"18","author":"S Kl\u00fcter","year":"2019","unstructured":"Kl\u00fcter S (2019) Technical design and concept of a 0.35 T MR-Linac. Clin Transl Radiat Oncol 18:98\u2013101. https:\/\/doi.org\/10.1016\/j.ctro.2019.04.007","journal-title":"Clin Transl Radiat Oncol"},{"key":"2056_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejmp.2021.05.002","volume":"85","author":"L Placidi","year":"2021","unstructured":"Placidi L, Nardini M, Cusumano D et al (2021) VMAT-like plans for magnetic resonance guided radiotherapy: addressing unmet needs. Phys Med 85:72\u201378. https:\/\/doi.org\/10.1016\/j.ejmp.2021.05.002","journal-title":"Phys Med"},{"key":"2056_CR24","doi-asserted-by":"publisher","unstructured":"Kong F-M (Spring), Ritter T, Quint DJ et al (2011) Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys 81:1442\u20131457. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.07.1977","DOI":"10.1016\/j.ijrobp.2010.07.1977"},{"key":"2056_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.prro.2013.06.004","volume":"4","author":"SK Jabbour","year":"2014","unstructured":"Jabbour SK, Hashem SA, Bosch W et al (2014) Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus. Pract Radiat Oncol 4:82\u201389. https:\/\/doi.org\/10.1016\/j.prro.2013.06.004","journal-title":"Pract Radiat Oncol"},{"key":"2056_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00066-011-0015-x","volume":"188","author":"N Hodapp","year":"2012","unstructured":"Hodapp N (2012) Der ICRU-report 83: verordnung, dokumentation und kommunikation der fluenzmodulierten photonenstrahlentherapie (IMRT). Strahlenther Onkol 188:97\u2013100. https:\/\/doi.org\/10.1007\/s00066-011-0015-x","journal-title":"Strahlenther Onkol"},{"key":"2056_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00066-018-1416-x","volume":"195","author":"L Wilke","year":"2019","unstructured":"Wilke L, Andratschke N, Blanck O et al (2019) ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams: statement from the DEGRO\/DGMP working group stereotactic radiotherapy and radiosurgery. Strahlenther Onkol 195:193\u2013198. https:\/\/doi.org\/10.1007\/s00066-018-1416-x","journal-title":"Strahlenther Onkol"},{"key":"2056_CR28","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1118\/1.3438081","volume":"37","author":"SH Benedict","year":"2010","unstructured":"Benedict SH, Yenice KM, Followill D et al (2010) Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 37:4078\u20134101. https:\/\/doi.org\/10.1118\/1.3438081","journal-title":"Med Phys"},{"key":"2056_CR29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.radonc.2017.07.028","volume":"125","author":"O Bohoudi","year":"2017","unstructured":"Bohoudi O, Bruynzeel AME, Senan S et al (2017) Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer. Radiother Oncol 125:439\u2013444. https:\/\/doi.org\/10.1016\/j.radonc.2017.07.028","journal-title":"Radiother Oncol"},{"key":"2056_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.tipsro.2020.06.001","volume":"15","author":"L Placidi","year":"2020","unstructured":"Placidi L, Romano A, Chiloiro G et al (2020) On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: clinical and dosimetric considerations. Tech Innov Patient Support Radiat Oncol 15:15\u201321. https:\/\/doi.org\/10.1016\/j.tipsro.2020.06.001","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"2056_CR31","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/0360-3016(93)90548-a","volume":"27","author":"E Shaw","year":"1993","unstructured":"Shaw E, Kline R, Gillin M et al (1993) Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys 27:1231\u20131239. https:\/\/doi.org\/10.1016\/0360-3016(93)90548-a","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2056_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"2056_CR33","unstructured":"National Cancer Institute (NCI) (2017) Common Terminology Criteria for Adverse Events (CTCAE)"},{"key":"2056_CR34","doi-asserted-by":"publisher","unstructured":"Remon J, Soria J-C, Peters S, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org (2021) Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy. Ann Oncol 32:1637\u20131642. https:\/\/doi.org\/10.1016\/j.annonc.2021.08.1994","DOI":"10.1016\/j.annonc.2021.08.1994"},{"key":"2056_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005212","volume":"95","author":"NP Nguyen","year":"2016","unstructured":"Nguyen NP, Godinez J, Shen W et al (2016) Is surgery indicated for elderly patients with early stage nonsmall cell lung cancer, in the era of stereotactic body radiotherapy? Medicine (Baltimore) 95:e5212. https:\/\/doi.org\/10.1097\/MD.0000000000005212","journal-title":"Medicine (Baltimore)"},{"key":"2056_CR36","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/JTO.0000000000000416","volume":"10","author":"A Mellemgaard","year":"2015","unstructured":"Mellemgaard A, L\u00fcchtenborg M, Iachina M et al (2015) Role of comorbidity on survival after radiotherapy and chemotherapy for nonsurgically treated lung cancer. J Thorac Oncol 10:272\u2013279. https:\/\/doi.org\/10.1097\/JTO.0000000000000416","journal-title":"J Thorac Oncol"},{"key":"2056_CR37","doi-asserted-by":"publisher","unstructured":"van der Voort van Zyp NC, van der Holt B, van Klaveren RJ, et al (2010) Stereotactic body radiotherapy using real-time tumor tracking in octogenarians with non-small cell lung cancer. Lung Cancer 69:296\u2013301. https:\/\/doi.org\/10.1016\/j.lungcan.2009.12.008","DOI":"10.1016\/j.lungcan.2009.12.008"},{"key":"2056_CR38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1748-717X-9-138","volume":"9","author":"S Hayashi","year":"2014","unstructured":"Hayashi S, Tanaka H, Kajiura Y et al (2014) Stereotactic body radiotherapy for very elderly patients (age, greater than or equal to 85 years) with stage I non-small cell lung cancer. Radiat Oncol 9:138. https:\/\/doi.org\/10.1186\/1748-717X-9-138","journal-title":"Radiat Oncol"},{"key":"2056_CR39","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1186\/1471-2407-14-971","volume":"14","author":"NA Cannon","year":"2014","unstructured":"Cannon NA, Iyengar P, Choy H et al (2014) Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study. BMC Cancer 14:971. https:\/\/doi.org\/10.1186\/1471-2407-14-971","journal-title":"BMC Cancer"},{"key":"2056_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/0300891620920709","volume":"107","author":"L Boldrini","year":"2021","unstructured":"Boldrini L, Colloca GF, Villani E et al (2021) Magnetic resonance-guided radiotherapy feasibility in elderly cancer patients: proposal of the MASTER scoring system. Tumori 107:26\u201331. https:\/\/doi.org\/10.1177\/0300891620920709","journal-title":"Tumori"},{"key":"2056_CR41","doi-asserted-by":"publisher","unstructured":"Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, Escriu C, Peters S (2017) Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 28:iv1\u2013iv21. https:\/\/doi.org\/10.1093\/annonc\/mdx222","DOI":"10.1093\/annonc\/mdx222"},{"key":"2056_CR42","doi-asserted-by":"publisher","unstructured":"Chen H, Laba JM, Zayed S, Boldt RG, Palma DA, Louie AV (2019) Safety and effectiveness of stereotactic ablative radiotherapy for ultra-central lung lesions: a systematic review. J Thoracic Oncol 14(8):1332\u20131342. https:\/\/doi.org\/10.1016\/j.jtho.2019.04.018","DOI":"10.1016\/j.jtho.2019.04.018"},{"key":"2056_CR43","doi-asserted-by":"publisher","unstructured":"Lindberg K, Grozman V, Karlsson K, Lindberg S, Lax I, Wers\u00e4ll P, Persson GF, Josipovic M, Khalil AA, Moeller DS, Nyman J, Drugge N, Bergstr\u00f6m P, Olofsson J, Rogg LV, Ramberg C, Kristiansen C, Jeppesen SS, Nielsen TB, Lewensohn R (2021) The HILUS-trial\u2014a prospective nordic multicenter phase 2 study of ultracentral lung tumors treated with stereotactic body radiotherapy. J Thoracic Oncol 16(7):1200\u20131210. https:\/\/doi.org\/10.1016\/j.jtho.2021.03.019","DOI":"10.1016\/j.jtho.2021.03.019"},{"key":"2056_CR44","doi-asserted-by":"publisher","unstructured":"Franceschini D, de Rose F, Cozzi L, Navarria P, Clerici E, Franzese C, Comito T, Tozzi A, Iftode C, D\u2019Agostino G, Sorsetti M (2017) Radical hypo-fractionated radiotherapy with volumetric modulated arc therapy in lung cancer: a retrospective study of elderly patients with stage\u00a0III disease. Strahlentherapie Und Onkologie: Organ Der Deutschen Rontgengesellschaft ... [et Al], 193(5):385\u2013391. https:\/\/doi.org\/10.1007\/s00066-017-1103-3","DOI":"10.1007\/s00066-017-1103-3"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-025-02056-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-025-02056-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-025-02056-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T11:25:21Z","timestamp":1761132321000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-025-02056-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":44,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["2056"],"URL":"https:\/\/doi.org\/10.1007\/s11547-025-02056-1","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LB had active research agreements with Roche and ViewRay Systems, Inc. and received speaker honoraria for scientific presentations and travel reimbursements. LP reports a consulting agreement and research grants with ViewRay Systems, Inc. outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This research study was conducted retrospectively in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This is a retrospective, observational study for which ethical approval from the Fondazione Gemelli Ethics Committee is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}